Severs M, Mangen MJ, van der Valk ME, Fidder HH, Dijkstra G, van der Have M, van Bodegraven AA, de Jong DJ, van der Woude CJ, Romberg-Camps MJ, Clemens CH, Jansen JM, van de Meeberg PC, Mahmmod N, Ponsioen CY, Vermeijden JR, van der Meulen-de Jong AE, Pierik M, Siersema PD, Oldenburg B; COIN study group and the Dutch Initiative on Crohn and Colitis. J Crohns Colitis. 2017 Mar 1; 11(3):342-252
Publicaties uit 2017
Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease
Severs M, Mangen MJ, Fidder HH, van der Valk ME, van der Have M, van Bodegraven AA,m Clemens CHM, Dijkstra G, Jansen JM, de Jong DJ, Mahmmod N, van de Meeberg PC, van der Meulen-de Jong, AE, Pierik M, Ponsioen CY, Romberg-Camps MJL, Siersema PD, Jharap B, van der Woude JC, Zuithoff NPA, Oldenburg B. Inflamm Bowel Dis. 2017 Sep;23(9):1568-1576
The impact of ethnicity and country of birth on inflammatory bowel disease phenotype, a prospective cohort study
Spekhorst LM, Severs M, de Boer KHN, et al.; on behalf of the Parelsnoer Institute (PSI) and the Dutch Initiative on Crohn and Colitis (ICC). J Crohns Colitis 2017
Cohort profile: Design and first results of the Dutch IBD Biobank: a porspective, nationwide biobank of patients with inflammatory bowel disease
Spekhorst LM, Imhann F, Festen EAM, van Bodegraven AA, de Boer NKH, Bouma G, Fidder HH, D’Haens GRAM, Hoentjen F, Hommes DW, de Jong DJ, Löwenberg M, Maljaars PWJ, van der Meulen-de Jong AE, Oldenburg B, Pierik MJ, Ponsioen CY, Stokkers PC, Verspaget HW, Visschedijk MC, van der Woude CJ, Dijkstra G, Weersma RK on behlaf of the Parelsnoer Institute (PSI) and the Dutch Initiative on Crohn and Colitis (ICC). BMJ 2017: in press